Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant in Insomnia Disorder
NCT07843329Phase 3Not yet recruiting
- Sponsor
- Idorsia
- Start
- Sep 2026
- Primary completion
- Nov 2027
01
Overview
A Phase 3 trial of daridorexant in insomnia disorder, sponsored by Idorsia. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
daridorexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT07843329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843329.